Current trends and perspectives of bioactive peptides

Area of Science:

• Biochemistry
• Pharmacology
• Food Science

Background:

• Therapeutic peptide development has seen significant growth, with market value projected to reach $25 billion by 2018.
• This expansion is fueled by rising metabolic and cardiovascular diseases and advances in peptide synthesis technology.
• Consequently, research into bioactive peptides has surged exponentially.

Purpose of the Study:

• To review the current landscape of therapeutic peptide development.
• To identify key drivers and obstacles in the field.
• To highlight areas requiring further research and development.

Main Methods:

• Literature review of market trends and scientific publications.
• Analysis of factors influencing peptide production and application.
• Examination of challenges in clinical validation and safety.

Main Results:

• Numerous bioactive peptides from various sources show health benefits.
• Significant challenges persist in industrial-scale production and cost-effectiveness.
• Need for robust clinical trials to substantiate health claims is critical.

Conclusions:

• Despite promising health effects, industrial-scale production and regulatory approval face hurdles.
• Ensuring peptide stability during digestion, safety, and efficacy requires further investigation.
• Addressing allergenicity, toxicity, and functional stability is crucial for therapeutic peptide advancement.